High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.
about
PrionsSolution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoformRapid folding of the prion protein captured by pressure-jumpCopper binding to the prion protein: structural implications of four identical cooperative binding sitesCopper(II)-induced conformational changes and protease resistance in recombinant and cellular PrP. Effect of protein age and deamidation.High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility.Mapping the prion protein using recombinant antibodies.Protease-sensitive synthetic prions.Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexibleInteractions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP.Molecular interactions between prions as seeds and recombinant prion proteins as substrates resemble the biological interspecies barrier in vitroAffinity-tagged miniprion derivatives spontaneously adopt protease-resistant conformationsSearch for a prion-specific nucleic acid.The role of dimerization in prion replicationConformation-dependent high-affinity monoclonal antibodies to prion proteins.Detection of prion protein particles in blood plasma of scrapie infected sheep.Human prions and plasma lipoproteins.A survey of antiprion compounds reveals the prevalence of non-PrP molecular targets.Structural studies of truncated forms of the prion protein PrP.Glycosylation of prion strains in transmissible spongiform encephalopathies.Prion Protein-Antibody Complexes Characterized by Chromatography-Coupled Small-Angle X-Ray Scattering.Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 Balb/cJ mice with purified scrapie prionsSlow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein.Mechanisms of prion protein assembly into amyloidThe peculiar nature of unfolding of the human prion protein.Convergent replication of mouse synthetic prion strains.Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.Structural changes of membrane-anchored native PrP(C)Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targetsPurification and fibrillation of full-length recombinant PrP.Recombinant scrapie-like prion protein of 106 amino acids is soluble.An emerging concept of prion infections as a form of transmissible cerebral amyloidosis.Prion proteins with pathogenic and protective mutations show similar structure and dynamics.Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease.Design and construction of diverse mammalian prion strainsQuiescin-sulfhydryl oxidase inhibits prion formation in vitro.De novo mammalian prion synthesis.Emergence and natural selection of drug-resistant prions.Role of lipid in forming an infectious prion?Disulfide bonds in amyloidogenesis diseases related proteins.
P2860
Q24633319-DA01ED86-2F8C-4AC3-87A5-DEC03B9C2D2BQ27743024-DB1EDE45-F36A-467C-96D9-4DE9EC7AB97FQ28236967-C611AEC9-8DB0-44E9-A5FC-294F49B19CB2Q30558995-C78CC938-35E6-49F1-A934-4068895F63F5Q30881188-23852244-9E43-486E-95D0-608D145D14F3Q31707696-417B9062-8202-4EE2-B5C0-76B1F03B3759Q32003051-95B36746-BE0F-4AE4-B6CC-61982CE5F7DEQ33526987-2047E1EC-DCA2-4486-830F-F079D7CA4184Q33705415-246CC3D0-BB97-4847-BD67-BE122BA2398BQ33736607-1723382E-A13F-4826-BCEB-A8BCB41FE430Q33769143-5A894344-C235-4D9C-9C5D-75507EFED3A2Q33813167-244D4BDF-8C3F-4E4E-BB1B-BF1AE115B328Q33911902-8C25A879-C582-4D62-B104-7BDF95419E2BQ34177517-F9E275AD-421D-4855-8C42-BF3FC0205776Q34211212-20F675ED-F594-423B-A99E-B8C75B7A32D1Q34261862-CB081E00-5A8D-4D53-9D0E-73B2960CC4C1Q34983985-FDA98EF5-68ED-435E-BBE9-99402781D538Q35145020-D976C562-7BFB-4EA0-98FF-4537EE36A123Q35221753-B384E0B0-545B-4A09-AE13-44D001FA4CABQ35794935-231D3268-E363-4AA7-9778-1FA75BE408B5Q35989584-CB04B218-5666-4C50-9E5A-82A2D40F5814Q36351017-A54A7654-3929-4986-AE1A-07B0948E3E43Q36436182-D6875DD1-E307-4AD8-BD9C-DC36D8D25109Q36497270-3903B0E6-D4D4-4998-8B81-612076FFC610Q36526502-EB0E9766-6D68-4E3A-856E-9B96EBDE3CA2Q36651921-D4F18110-EE35-4CB6-A778-22AD6288A977Q36806239-5227E298-EE09-4354-8944-6CEE91571DDFQ36825306-010B44E4-6746-45E7-8161-D50DA0C5F5DCQ36978208-55BF75C5-B343-4E78-9685-11C6DBAFA258Q37032773-A3E34DF8-978A-4617-9C47-45504310297AQ37096971-FDB22F0D-A10D-4ECB-AD75-6412DCCE3E85Q37378386-72F87855-FF18-4E6C-9044-B373AF10F758Q37388684-8C24267E-F78E-47EE-91EB-C74882DFB545Q37452196-7FE03A05-83FA-400E-A458-89226093D492Q37453512-5CC5C1C1-8DAF-43CB-9BF2-16C4B6586ABFQ37610204-4672F1B8-459E-40E3-85F4-EB6A27CEB3EAQ37627076-04D2B63E-D0D9-44C2-B882-8322AADBA51DQ37737577-46C9F0A4-8C93-4E18-A105-FCCC54BF83FFQ38098826-A75CB453-D85F-41E1-9380-58452C8F5A6FQ38113990-F3FFBDF1-2F0F-420D-BD9A-88E8041B4CA3
P2860
High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
High-level expression and char ...... ypeptide of the prion protein.
@en
High-level expression and char ...... ypeptide of the prion protein.
@nl
type
label
High-level expression and char ...... ypeptide of the prion protein.
@en
High-level expression and char ...... ypeptide of the prion protein.
@nl
prefLabel
High-level expression and char ...... ypeptide of the prion protein.
@en
High-level expression and char ...... ypeptide of the prion protein.
@nl
P2093
P356
P1433
P1476
High-level expression and char ...... ypeptide of the prion protein.
@en
P2093
Fletterick R
Mehlhorn I
Willett WS
P304
P356
10.1021/BI952965E
P407
P577
1996-04-01T00:00:00Z